Document is current
Any future updates will be listed below
-
Authors
Suzuki, Takanori
Inoue, Takako
Matsuura, Kentaro
Kusumoto, Shigeru
Hagiwara, Shinya
Ogawa, Shintaro
Yagi, Shintaro
Kaneko, Atsushi
Fujiwara, Kei
Watanabe, Takehisa
Aoyagi, Katsumi
Urata, Yukitomo
Tamori, Akihiro
Kataoka, Hiromi
Tanaka, Yasuhito https://orcid.org/0000-0002-2473-6966
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP20fk0310101)
Japan Agency for Medical Research and Development (JP21fk0310101)
- License Information
-
More Information
Article History
Received: 12 January 2022
Accepted: 19 March 2022
First Online: 28 April 2022
Declarations
:
: Takako Inoue: Consigned/Joint Research Expenses: Fujirebio, Inc. and Sysmex Corporation. Shigeru Kusumoto: Research funding from Chugai Pharmaceutical Co., Ltd., Kyowa Kirin Co., Ltd., and honoraria from Chugai Pharmaceutical Co., Ltd., Zennyaku Kogyo Co. Ltd. and Bristol-Myers Squibb. Yasuhito Tanaka: Research funding from Chugai Pharmaceutical Co., Ltd., Fujirebio, Inc., and Gilead Sciences. Lecture fees from Fujirebio, Inc. and Gilead Sciences.
